EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How mNGS transforms care for non-verbal elderly stroke patients with pneumonia

Yuhai Dang

Frontiers in Cellular and Infection Microbiology · 23.06.2026 · 16

DOI: 10.3389/fcimb.2026.1814320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 23.06.2026. Verfasst von Yuhai Dang. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Guangxi Jiangbin Hospital, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Stroke, Pneumonia. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stroke-associated pneumonia (SAP) is a severe complication in non-verbal elderly stroke patients, with diagnosis hindered by the low sensitivity and slow turnaround of conventional microbial culture.

Methods

A single-center retrospective cohort study was conducted on 64 non-verbal elderly SAP patients (≥65 years) admitted to Guangxi Jiangbin Hospital from 2018 to 2022, divided into an mNGS group (n=30, sputum/BALF tested by metagenomic next-generation sequencing) and a control group (n=34, conventional culture). Propensity score matching (1:1) was used to balance baseline characteristics, and clinical outcomes and pathogen detection efficiency were compared between groups. Multivariable Cox regression adjusted for hypoalbuminemia, electrolyte disturbance and stroke severity. Results mNGS detected more bacterial pathogens (37 vs.27 in sputum, 37 vs.21 in BALF) and identified 3 viral and 2 atypical pathogens undetectable by culture, with a negative rate of 13.3% (vs.20.0% for sputum culture, 43.3% for BALF culture). 73.3% of mNGS group patients received antimicrobial therapy adjustment. After adjustment, the mNGS group had notably higher 28-day (96.7% vs.76.5%; adjusted HR = 0.32, P = 0.032) and 90-day survival (76.7% vs.44.1%; adjusted HR = 0.41, P = 0.024), lower invasive mechanical ventilation rate (40.0% vs.64.7%, P = 0.048), shorter median antibiotic duration (14 vs.21 days, P = 0.016) and lower median hospitalization costs (¥32,450 vs.¥89,310, P < 0.001). Conclusion mNGS enables more comprehensive pathogen detection in non-verbal elderly SAP patients, guides targeted antimicrobial therapy, and is associated with improved survival and reduced healthcare resource consumption. However, large-sample multicenter prospective studies are needed to validate these findings due to the study’s limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokePneumoniaHumansAgedRetrospective StudiesFemaleMaleSputumAged, 80 and overBronchoalveolar Lavage FluidBacteriaAnti-Bacterial AgentsHigh-Throughput Nucleotide SequencingMetagenomics

Stichwörter der Autor:innen

antimicrobial stewardshipelderlymetagenomic next-generation sequencingmortalitynon-verbalpathogen detectionstroke-associated pneumonia

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Guangxi Jiangbin Hospital, Nanning, Guangxi, China.

Zitieren

APA

Dang, Y. (2026). How mNGS transforms care for non-verbal elderly stroke patients with pneumonia. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1814320

Vancouver

Dang Y. How mNGS transforms care for non-verbal elderly stroke patients with pneumonia. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1814320

BibTeX
@article{Dang2026,
  author = {Dang, Yuhai},
  title = {How mNGS transforms care for non-verbal elderly stroke patients with pneumonia},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1814320}
}
Kostenlos starten →